BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16327184)

  • 21. The effect of some excipients on the physical properties of a paracetamol tablet formulation.
    Esezobo S
    J Pharm Pharmacol; 1985 Mar; 37(3):193-5. PubMed ID: 2858567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.
    Puri D; Bhandari A; Gaur PK; Yasir M; Kumar SS; Choudhary D; Saxena PK
    Curr Clin Pharmacol; 2018; 13(2):128-135. PubMed ID: 29521214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
    Hooper P; Lasher J; Alexander KS; Baki G
    J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of Microcrystalline Cellulose for Improving Drug Content Uniformity in Tablet Manufacturing Using Direct Powder Compression.
    Nakamura S; Tanaka C; Yuasa H; Sakamoto T
    AAPS PharmSciTech; 2019 Mar; 20(4):151. PubMed ID: 30903317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.
    Khan S; Kataria P; Nakhat P; Yeole P
    AAPS PharmSciTech; 2007 Jun; 8(2):Article 46. PubMed ID: 17622121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fast disintegrating tablets containing Rhodiola rosea L. extract.
    Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
    Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and evaluation of novel directly-compressed fast-disintegrating furosemide tablets with sucrose stearic acid ester.
    Koseki T; Onishi H; Takahashi Y; Uchida M; Machida Y
    Biol Pharm Bull; 2009 Jun; 32(6):1126-30. PubMed ID: 19483329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication and optimization of fast disintegrating tablets employing interpolymeric chitosan-alginate complex and chitin as novel superdisintegrants.
    Goel H; Tiwary AK; Rana V
    Acta Pol Pharm; 2011; 68(4):571-83. PubMed ID: 21796940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion-precipitation method.
    Randale SA; Dabhi CS; Tekade AR; Belgamwar VS; Gattani SG; Surana SJ
    Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):443-8. PubMed ID: 20410620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of preparation method on properties of orally disintegrating tablets made by phase transition.
    Kuno Y; Kojima M; Ando S; Nakagami H
    Int J Pharm; 2008 May; 355(1-2):87-92. PubMed ID: 18182258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of tablet hardness based on near infrared spectra of raw mixed powders by chemometrics.
    Otsuka M; Yamane I
    J Pharm Sci; 2006 Jul; 95(7):1425-33. PubMed ID: 16721793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digital Image Disintegration Analysis: a Novel Quality Control Method for Fast Disintegrating Tablets.
    Malallah O; Rashid Z; Li CL; Alqurshi A; Alhanan MA; Forbes B; Royall PG
    AAPS PharmSciTech; 2021 Aug; 22(7):219. PubMed ID: 34401966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA; Augsburger LL
    Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests.
    Momeni M; Afkanpour M; Rakhshani S; Mehrabian A; Tabesh H
    BMC Med Inform Decis Mak; 2024 Mar; 24(1):88. PubMed ID: 38539201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.